SUPPLEMENT

Q2 2025 — Income statement trends

Q2 2025PDF · 2 pages144 KB
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q223 	Q323 	Q423 	Q124 	Q224 	Q324 	Q424 	Q125 	Q225
Revenues:
Clearing and transaction fees 	1,118.3 	1,085.5 	1,184.5 	1,208.9 	1,249.9 	1,297.1 	1,232.3 	1,337.3 	1,388.0
Market data and information services 	163.1 	167.6 	167.2 	175.4 	175.0 	178.2 	181.6 	194.5 	198.1
Other Revenue 	78.8 	84.7 	87.6 	103.6 	107.6 	109.1 	111.4 	110.5 	105.9
Total revenues 	1,360.2 	1,337.8 	1,439.3 	1,487.9 	1,532.5 	1,584.4 	1,525.3 	1,642.3 	1,692.0
Expenses:
Compensation and benefits 	205.7 	205.5 	212.9 	206.0 	204.7 	218.8 	220.8 	206.7 	221.6
Technology 	53.3 	55.6 	58.5 	59.4 	64.1 	66.6 	65.7 	65.7 	70.9
Professional fees and outside services 	37.8 	32.2 	36.1 	33.1 	34.7 	31.0 	33.9 	28.5 	37.4
Amortization of purchased intangibles 	57.0 	57.2 	55.6 	55.2 	55.5 	55.7 	55.3 	55.2 	56.1
Depreciation and amortization 	32.3 	31.1 	30.7 	30.1 	28.7 	28.2 	28.1 	27.3 	27.3
Licensing and other fee agreements 	78.2 	79.5 	80.4 	87.9 	85.9 	97.6 	84.0 	96.6 	96.2
Other expense 	57.3 	56.5 	101.9 	56.6 	58.3 	62.3 	90.4 	54.3 	53.2
Operating expenses 	521.6 	517.6 	576.1 	528.3 	531.9 	560.2 	578.2 	534.3 	562.7
Operating Income 	838.6 	820.2 	863.2 	959.6 	1,000.6 	1,024.2 	947.1 	1,108.0 	1,129.3
Operating Margin 	62% 	61% 	60% 	64% 	65% 	65% 	62% 	67% 	67%
Non-operating Income and Expense
Investment income 	1,568.2 	1,272.5 	1,076.9 	1,071.3 	1,044.5 	1,026.8 	936.5 	892.7 	1,518.4
Interest and other borrowing costs 	(40.2) 	(39.6) 	(39.7) 	(39.9) 	(40.1) 	(40.2) 	(40.7) 	(41.7) 	(44.0)
Equity in net gains (losses) of unconsolidated subsidiaries 	75.1 	76.8 	66.8 	87.2 	86.4 	86.1 	91.2 	88.2 	99.0
Other non-operating income (expense) 	(1,425.3) 	(1,155.6) 	(961.2) 	(964.8) 	(936.9) 	(920.0) 	(837.5) 	(802.4) 	(1,372.4)
Non-operating income (expense) 	177.8 	154.1 	142.8 	153.8 	153.9 	152.7 	149.5 	136.8 	201.0
Income before income taxes 	1,016.4 	974.3 	1,006.0 	1,113.4 	1,154.5 	1,176.9 	1,096.6 	1,244.8 	1,330.3
Income taxes 	238.8 	224.1 	191.4 	258.2 	271.3 	264.1 	222.0 	288.6 	305.2
Net income 	777.6 	750.2 	814.6 	855.2 	883.2 	912.8 	874.6 	956.2 	1,025.1
Less: net income (loss) attributable to NCI 	- 	- 	- 	- 	- 	- 	- 	- 	-
Net Income Attributable to CME Group 	777.6 	750.2 	814.6 	855.2 	883.2 	912.8 	874.6 	956.2 	1,025.1
Net Income Attributable to Common Shareholders of CME Group 	767.8 	740.8 	804.3 	844.4 	872.1 	901.3 	863.7 	944.2 	1,012.2
Effective Tax Rate 	23.5% 	23.0% 	19.0% 	23.2% 	23.5% 	22.4% 	20.2% 	23.2% 	22.9%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	2.14 	2.06 	2.24 	2.35 	2.43 	2.51 	2.40 	2.63 	2.81
Diluted EPS 	2.14 	2.06 	2.24 	2.35 	2.42 	2.50 	2.40 	2.62 	2.81
Weighted average number of common stock shares:
Basic Shares 	358,940 	359,020 	359,197 	359,258 	359,330 	359,400 	359,568 	359,613 	359,658
Diluted Shares 	359,429 	359,619 	359,693 	359,833 	359,869 	359,989 	360,050 	360,227 	360,355
Preferred Shares 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584

-- 1 of 2 --

CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NON-GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q223 	Q323 	Q423 	Q124 	Q224 	Q324 	Q424 	Q125 	Q225
Revenues:
Clearing and transaction fees 	1,118.3 	1,085.5 	1,184.5 	1,208.9 	1,249.9 	1,297.1 	1,232.3 	1,337.3 	1,388.0
Market data and information services 	163.1 	167.6 	167.2 	175.4 	175.0 	178.2 	181.6 	194.5 	198.1
Other Revenue 	78.8 	84.7 	87.6 	103.6 	106.6 	109.2 	111.3 	110.5 	105.9
Total revenues 	1,360.2 	1,337.8 	1,439.3 	1,487.9 	1,531.5 	1,584.5 	1,525.2 	1,642.3 	1,692.0
Expenses:
Compensation and benefits 	194.4 	193.5 	204.4 	196.1 	201.7 	207.5 	218.9 	207.8 	212.5
Technology 	53.3 	55.6 	58.5 	59.4 	64.1 	66.6 	65.7 	65.7 	70.9
Professional fees and outside services 	37.8 	32.2 	36.1 	33.1 	34.7 	31.0 	33.9 	25.2 	27.0
Amortization of purchased intangibles 	- 	- 	- 	- 	- 	- 	- 	- 	-
Depreciation and amortization 	31.8 	31.1 	29.8 	29.3 	28.7 	28.2 	28.0 	27.3 	26.9
Licensing and other fee agreements 	78.2 	79.5 	80.4 	87.9 	85.9 	97.6 	84.0 	96.6 	96.2
Other expense 	56.2 	56.5 	80.3 	56.5 	58.6 	57.9 	89.7 	52.0 	57.7
Operating expenses 	451.7 	448.4 	489.5 	462.3 	473.7 	488.8 	520.2 	474.6 	491.2
Operating Income 	908.5 	889.4 	949.8 	1,025.6 	1,057.8 	1,095.7 	1,005.0 	1,167.7 	1,200.8
Operating Margin 	67% 	66% 	66% 	69% 	69% 	69% 	66% 	71% 	71%
Non-operating Income and Expense
Investment income 	1,564.0 	1,276.6 	1,068.5 	1,061.7 	1,033.0 	1,022.3 	943.8 	892.3 	1,510.7
Interest and other borrowing costs 	(40.2) 	(39.6) 	(39.7) 	(39.9) 	(40.1) 	(40.2) 	(40.7) 	(41.7) 	(44.0)
Equity in net gains (losses) of unconsolidated subsidiaries 	88.6 	90.4 	85.1 	100.7 	98.8 	99.7 	104.8 	110.4 	112.2
Other non-operating income (expense) 	(1,429.9) 	(1,157.1) 	(958.8) 	(964.8) 	(936.9) 	(920.0) 	(837.5) 	(802.4) 	(1,372.4)
Non-operating income (expense) 	182.5 	170.3 	155.1 	157.7 	154.8 	161.8 	170.4 	158.6 	206.5
Income before income taxes 	1,091.0 	1,059.7 	1,104.9 	1,183.3 	1,212.6 	1,257.5 	1,175.4 	1,326.3 	1,407.3
Income taxes 	254.6 	241.7 	240.2 	272.2 	280.4 	280.5 	256.5 	306.4 	327.9
Net income 	836.4 	818.0 	864.7 	911.1 	932.2 	977.0 	918.9 	1,019.9 	1,079.4
Less: net income (loss) attributable to NCI 	- 	- 	- 	- 	- 	- 	- 	- 	-
Net Income Attributable to CME Group 	836.4 	818.0 	864.7 	911.1 	932.2 	977.0 	918.9 	1,019.9 	1,079.4
Net Income Attributable to Common Shareholders of CME Group 	825.9 	807.8 	853.8 	899.7 	920.4 	964.7 	907.4 	1,007.1 	1,065.8
Effective Tax Rate 	23.3% 	22.8% 	21.7% 	23.0% 	23.1% 	22.3% 	21.8% 	23.1% 	23.3%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	2.30 	2.25 	2.38 	2.50 	2.56 	2.68 	2.52 	2.80 	2.96
Diluted EPS 	2.30 	2.25 	2.37 	2.50 	2.56 	2.68 	2.52 	2.80 	2.96
Weighted average number of common stock shares:
Basic Shares 	358,940 	359,020 	359,197 	359,258 	359,330 	359,400 	359,568 	359,613 	359,658
Diluted Shares 	359,429 	359,619 	359,693 	359,833 	359,869 	359,989 	360,050 	360,227 	360,355
Preferred Shares 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584

-- 2 of 2 --